Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2017

Open Access 01-12-2017 | Case report

Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature

Authors: Jiheun Han, Eun Young Ki, Sung Eun Rha, SooYoung Hur, Ahwon Lee

Published in: World Journal of Surgical Oncology | Issue 1/2017

Login to get access

Abstract

Background

Dedifferentiated endometrioid adenocarcinoma (DEAC) is rare and is known to be more aggressive than high-grade endometrioid carcinoma. Differentiating between the two is important to provide appropriate treatment for patients.

Case presentation

This is a retrospective study including four cases of DEAC of the uterus, which was diagnosed and treated in our Obstetrics and Gynecology department between January 2013 and December 2015. Clinical, pathological, and immunohistochemical staining features are discussed. Each tumor was composed of undifferentiated carcinoma (UC) and low-grade endometrioid carcinoma with abrupt transition between them. Two patients showed recurrence or progression within one month postoperatively and died at the last follow-up. An immunohistochemical study showed PAX-8, ER, PR, and E-cadherin expression in UC component.

Conclusions

DEAC should not be underdiagnosed as conventional endometrioid adenocarcinoma due to its fulminant clinical course. Therefore, UC, including DEAC, should be further categorized to provide intensive treatment to improve patient survival.
Literature
1.
2.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014.
3.
Silva EG, Deavers MT, Bodurka DC, Malpica A. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006;25:52–8.CrossRefPubMed
4.
Ronnett BM, Zaino RJ, Ellenson LH, Kurman RJ. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer-Verlag; 2002. p. 501–59.
5.
Altrabulsi B, Malpica A, Deavers MT, Bodurka DC, Broaddus R, Silva EG. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol. 2005;29:1316–21.CrossRefPubMed
6.
Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol. 2010;23:781–9.CrossRefPubMed
7.
8.
Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15:e268–78.CrossRefPubMed
9.
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31:2607–18.CrossRefPubMedPubMedCentral
10.
Giordano G, Gnetti L, Merisio C, Melpignano M. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007;56:190–7.CrossRefPubMed
11.
Kanis MJ, Rahaman J, Moshier EL, Zakashansky K, Chuang L, Kolev V. Detection and correlation of pre-operative, frozen section, and final pathology in high-risk endometrial cancer. Eur J Gynaecol Oncol. 2016;37:338–41.PubMed
12.
Thomas S, Hussein Y, Bandyopadhyay S, Cote M, Hassan O, Abdulfatah E, et al. Interobserver variability in the diagnosis of uterine high-grade endometrioid carcinoma. Arch Pathol Lab Med. 2016;140:836–43.CrossRefPubMed
13.
Silva EG, Deavers MT, Malpica A. Undifferentiated carcinoma of the endometrium: a review. Pathology. 2007;39:134–8.CrossRefPubMed
14.
Ramalingam P, Masand RP, Euscher ED, Malpica A. Undifferentiated carcinoma of the endometrium: an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers. Int J Gynecol Pathol. 2016;35:410–8.CrossRefPubMed
15.
Li Z, Zhao C. Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016;24:562–8.CrossRefPubMed
16.
Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, et al. ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma. Mod Pathol. 2013;26:1514–24.CrossRefPubMed
17.
Garg K, Leitao Jr MM, Kauff ND, Hansen J, Kosarin K, Shia J, et al. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Am J Surg Pathol. 2009;33:925–33.CrossRefPubMed
18.
Shen Y, Wang Y, Shi Y, Liu J, Liu Y. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report. Int J Clin Exp Pathol. 2012;5:77–82.PubMedPubMedCentral
19.
Vita G, Borgia L, Di Giovannantonio L, Bisceglia M. Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case. Int J Surg Pathol. 2011;19:649–52.CrossRefPubMed
20.
Wu ES, Shih Ie M, Diaz-Montes TP. Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor? Gynecol Oncol Case Rep. 2013;5:25–7.CrossRefPubMedPubMedCentral
21.
Berretta R, Patrelli TS, Faioli R, Mautone D, Gizzo S, Mezzogiorno A, et al. Dedifferentiated endometrial cancer: an atypical case diagnosed from cerebellar and adrenal metastasis: case presentation and review of literature. Int J Clin Exp Pathol. 2013;6:1652–7.PubMedPubMedCentral
22.
Park SY, Park MH, Ko HS, Cha EJ, Sohn JS, Jung US, et al. Dedifferentiated endometrioid adenocarcinoma of the uterus: highly aggressive and poor prognostic tumor. Korean J Pathol. 2014;48:327–30.CrossRefPubMedPubMedCentral
23.
Soyama H, Takano M, Miyamoto M, Kato M, Goto T, Furuya K. Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report. Eur J Gynaecol Oncol. 2016;37:426–9.PubMed
24.
Rabban JT. Dedifferentiated endometrial carcinoma: An aggressive tumor that may morphologically mimic lower-grade endometrioid adenocarcinoma. AJSP: Reviews & Reports. 2016;21:57–72.
Metadata
Title
Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature
Authors
Jiheun Han
Eun Young Ki
Sung Eun Rha
SooYoung Hur
Ahwon Lee
Publication date
01-12-2017
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2017
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-016-1093-0

Other articles of this Issue 1/2017

World Journal of Surgical Oncology 1/2017 Go to the issue

Review

The significance of a nineteenth century definition in the era of genomics: linitis plastica

Research

Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma

Research

Surgical treatment of upper cervical spine metastases: a retrospective study of 39 cases

Research

Preoperative detection of pleural adhesions by respiratory dynamic computed tomography

Research

Statin consumption as a risk factor for developing colorectal cancer: a retrospective case study

Case Report

Mastalgia as an atypical presentation of hepatocellular carcinoma: a case report